| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090159877 Electroactive materials |
| 06/25/2009 | CA2708496A1 Gasoline composition and process for the preparation of alkylfurfuryl ether |
| 06/24/2009 | EP2072498A1 N-phenyloxamidic acid derivative |
| 06/24/2009 | EP1620421B1 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives |
| 06/24/2009 | EP1620093B1 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 06/24/2009 | EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 06/24/2009 | EP1311467B1 Method for producing phthalic anhydride |
| 06/24/2009 | CN101466686A C-FMS kinase inhibitor |
| 06/24/2009 | CN101463022A Preparation of Chinese medicine Yulansan chalcone monomer and use thereof |
| 06/24/2009 | CN101463021A Method and equipment for automatically and continuously producing furfuryl alcohol |
| 06/24/2009 | CN100505739C Method and system for low-overhead mobility management protocol in internet protocol layer |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503591C Phthalic anhydride reactor |
| 06/24/2009 | CN100503590C Method for synthetizing (S)3-hydroxy-gamma-butyrolactone by L-malate dioester catalytic hydrogenation |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/18/2009 | WO2009076627A2 Conversion of carbohydrates to hydroxy-methylfurfural (hmf) and derivatives |
| 06/18/2009 | WO2009075291A1 Optically active dinickel complex and method for producing optically active amine using the optically active dinickel complex as catalyst |
| 06/18/2009 | WO2009075112A1 Oxime ether derivative and bactericide for agricultural and horticultural use |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009030509A3 5-substituted 2-(alkoxymethyl)furans |
| 06/18/2009 | WO2009021126A3 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 06/18/2009 | WO2008156816A3 Renin inhibitors |
| 06/18/2009 | US20090156841 Conversion of carbohydrates to hydroxymethylfurfural (hmf) and derivatives |
| 06/18/2009 | US20090156835 Preparation of phthalic anhydride by gas phase oxidation of o-xylene in a main reactor and postreactor |
| 06/18/2009 | US20090156805 Cycloalkane Carboxamide Derivatives and Production Process of Same |
| 06/18/2009 | US20090156767 Substituted pyridine ligands and related water-soluble catalysts |
| 06/18/2009 | US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 06/18/2009 | US20090156668 Ginkgolide Compounds, Compositions, And Extracts, And Uses Thereof |
| 06/18/2009 | US20090156652 Therapeutic agent for food competence disorder in stomach |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 06/17/2009 | EP2070918A1 Bifunctional polymerizable compound, polymerizable liquid crystal composition, and oriented film |
| 06/17/2009 | EP2070917A1 Taste-improving agent and food or drink containing the same |
| 06/17/2009 | EP2069321A1 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof |
| 06/17/2009 | EP2069320A2 Process for the synthesis of ramelteon and its intermediates |
| 06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP2069287A1 Insecticidal compounds |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | CN101460474A 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
| 06/17/2009 | CN101456851A Method for preparing 5-hydroxymethyl-furfural by microwave promotion |
| 06/17/2009 | CN101456850A Method for preparing 5-hydroxymethyl-furfural |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/16/2009 | US7547697 Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors |
| 06/16/2009 | CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 06/16/2009 | CA2447640C Substituted anilide derivative, intermediate thereof, agricultural and horticultural chemical and its usage |
| 06/16/2009 | CA2414847C Process for the preparation of substituted octanoyl amides |
| 06/16/2009 | CA2370561C Process for the production of furfural from lignosulphonate waste liquor |
| 06/16/2009 | CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 06/11/2009 | WO2009071799A1 Process for the synthesis of 4-benzofurancarboxylic acid |
| 06/11/2009 | WO2009071252A1 Nonsteroidal progesterone receptor modulators |
| 06/11/2009 | WO2009055437A3 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease |
| 06/11/2009 | WO2009030508A4 Hydroxymethylfurfural ethers from sugars or hmf and mixed alcohols |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | WO2002065984A3 Compounds having retinoid-like activity |
| 06/11/2009 | US20090149663 Strontium (M) abscorbate compositions containing same, method for making same and method of using same |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149531 Chemical composition derived from p-hydroxyphenyl propionic acid for the treatment of psoriasis |
| 06/10/2009 | EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 06/10/2009 | EP2066620A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 06/10/2009 | EP2066615A2 Cyclopentane derivatives as antiglaucoma agents |
| 06/10/2009 | EP1532105B1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 06/10/2009 | DE102007058747A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497344C Preparation of high-purity ginkgolide |
| 06/10/2009 | CN100497328C Method for the production of determined mixtures of THF BDO and GBL by gas phase hydrogenation |
| 06/10/2009 | CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100497295C Process for the preparation of N-monosubstituted beta-amino alcohols |
| 06/10/2009 | CN100496718C Catalyst extrudate based on copper oxide and their use for hydrogenating carbonyl compounds |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544817 Reacting 3-(1-hydroxyalkylidene)-3H-benzofuran-2-one compounds or their 3-alkanoyl-3H-benzofuran-2-one ketonic tautomeric forms in the presence of a concentrated acid catalyst; intermediate for the antiarrhythmic dronedarone |
| 06/09/2009 | US7544810 Reacting an organic amine compound with a carbamyl-group-containing amide compound in the presence of a suitable polar or nonpolar aprotic, substantially anhydrous solvent or mixtures thereof; used as therapeutic agents for IMPDH-mediated diseases |
| 06/09/2009 | US7544800 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
| 06/09/2009 | CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 06/04/2009 | WO2009069714A1 Process for production of furan compound |
| 06/04/2009 | WO2009069602A1 Benzanthracene compound and organic electroluminescent device using the same |
| 06/04/2009 | WO2009069537A1 Light-emitting device material and light-emitting device |
| 06/04/2009 | WO2009069132A2 Novel reverse transcriptase inhibitors |
| 06/04/2009 | WO2009030505A3 Hydroxymethylfurfural ethers from hmf and olefins |
| 06/04/2009 | WO2009030504A3 Hydroxymethylfurfural ethers from sugars and olefins |
| 06/04/2009 | US20090143602 Esters of 5-hydroxymethylfurfural and methods for their preparation |
| 06/04/2009 | US20090143601 Method for preventing fumaric acid deposits in the production of maleic acid anhydride |
| 06/04/2009 | US20090143593 Synthesis of heterocyclic compounds |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143463 Therapeutic Agent and Treatment Method for Ameliorating Uremia |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143432 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
| 06/04/2009 | US20090143408 Compositions and methods for inhibiting cytochrome p450 2d6 |
| 06/04/2009 | US20090143369 Methods of using substituted morpholine and thiomorpholine derivatives |
| 06/03/2009 | EP2064199A1 Diaryl ether derivatives and uses thereof |
| 06/03/2009 | EP2064194A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |